The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 16, 2017

Filed:

Dec. 28, 2007
Applicants:

Pingyu Ding, Foster City, CA (US);

Dane Goff, Redwood City, CA (US);

Jing Zhang, Foster City, CA (US);

Rajinder Singh, Belmont, CA (US);

Sacha Holland, San Francisco, CA (US);

Jiaxin Yu, San Carlos, CA (US);

Thilo J. Heckrodt, San Francisco, CA (US);

Joane Litvak, Oakland, CA (US);

Inventors:

Pingyu Ding, Foster City, CA (US);

Dane Goff, Redwood City, CA (US);

Jing Zhang, Foster City, CA (US);

Rajinder Singh, Belmont, CA (US);

Sacha Holland, San Francisco, CA (US);

Jiaxin Yu, San Carlos, CA (US);

Thilo J. Heckrodt, San Francisco, CA (US);

Joane Litvak, Oakland, CA (US);

Assignee:

Rigel Pharmaceuticals Inc., South San Francsico, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/502 (2006.01); A61K 33/24 (2006.01); A61K 45/06 (2006.01); C07D 403/14 (2006.01); C07D 403/04 (2006.01); C07D 495/04 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 519/00 (2006.01); C07D 407/14 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 407/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 519/00 (2013.01);
Abstract

N-Heteroaryl substituted triazoles and N-heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.


Find Patent Forward Citations

Loading…